Stay updated on Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial

Sign up to get notified when there's something new on the Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays the clinical-trial record for the inhaled amikacin study, including its study design, eligibility criteria, locations, and outcomes, instead of a 403 error.
    Difference
    72%
    Check dated 2026-11-07T15:12:00.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T15:37:58.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website updates and a terminology change from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T16:48:31.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:31:19.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:51:37.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, showing a minimal header and a 403 title instead of the trial details. The page content that previously described the trial and its related sections has been removed.
    Difference
    17%
    Check dated 2026-09-19T19:05:46.000Z thumbnail image

Stay in the know with updates to Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial page.